Cambridge Health Alliance
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Cambridge Health Alliance sits in the top decile of US sponsors by registered trial count (#397 of 15,742 sponsors by registered trial count).
Cambridge Health Alliance: 45 sponsored US clinical trials, 7 recruiting.
Cambridge Health Alliance sponsors 45 registered US clinical trials on ClinicalTrials.gov, 7 of them currently recruiting, and 30 completed. 5 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pain Interference, with 1 trials.
Top-decile sponsor footprint
Cambridge Health Alliance ranks in the top decile of sponsors by registered trial count (#397 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
30 of 35 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
45 total, page 1 of 1
The Effectiveness and Acceptability of Formal Versus Informal Mindful Self-Compassion for Adolescents
NCT07513220
Exploring the Effects of Brief Mindfulness Training With Vagal Nerve Stimulation on Alcohol Cue Reactivity Among Young Adult Heavy Drinkers
NCT07516873
Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
NCT06988462
Treatment for Individuals Interacting with the Criminal Justice System
NCT06564948
Family Connections
NCT06662357
Our Whole Lives Gemini: Virtual Integrative Medical Group Visits for Managing Chronic Pain
NCT06515925
First Face Training Evaluation in Tribal Communities
NCT05998005
Program for Alleviating and Reducing Trauma and Stress for Intimate Partner Violence
NCT06765122
Using Data Science To Center Patient Perspectives in Mechanism Discovery
NCT06233968
"F!reF!ghterF!t": Lifestyle Coaching Interventions for Obese Firefighters (FireFit)
NCT06890975
Healing Lodge First Face Training Evaluation Study
NCT06290180
Program for Alleviating and Reducing Trauma, Stress, and Substance Use
NCT06207409
Heart-Smile Training Intensive Introduction Program
NCT05564533
Effects of RME on Engagement in Buprenorphine Treatment
NCT05184907
Program for Alleviating and Resolving Trauma and Stress 2
NCT05095428
Community and Familial Impacts of the Opioid Crisis
NCT05116852
Prevention and Early Identification for High Risk Youth in School-based Clinics
NCT04935710
The Safety-Net Approach
NCT04675567
Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use
NCT04595084
Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment (R33 Phase)
NCT04278586
Program for Alleviating and Resolving Trauma and Stress 1
NCT04713501
Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease
NCT04419025
MINDFUL-PC for Portuguese Speakers Pilot Study 2020
NCT04268355
Mindful Self-Regulation fMRI Study (MindfulPCfMRI)
NCT03609749
Integrating Mindfulness Into the Patient-Centered Medical Home (Phase 3)
NCT03609450
MINDFUL-OBOT: Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment
NCT03798431
Enhancing Systems of Care: Supporting Families and Improving Youth Outcomes
NCT03637478
Integrating Mindfulness Into the Patient-Centered Medical Home (Phase 2)
NCT03265600
MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)
NCT02942199
Mindful Self-Regulation fMRI Pilot Study
NCT02972853
MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home
NCT02972203
Improving Hospital-to-Home Care Transitions for High-risk Younger Adult Patients
NCT02532296
Evaluation Study for the Efficacy and Safety of PinPointe FootLaser in Treatment for Onychomycosis
NCT01920178
Post-Traumatic Stress Disorder (PTSD) and Seroquel
NCT01066156
Study of Patient Navigation to Promote Colon Cancer Screening
NCT01141114
An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.
NCT00391261
Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults
NCT01224067
An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders
NCT00308074
Taurine in Adolescents With Bipolar Disorder
NCT00391001
White Matter in Pediatric Bipolar Disorder: A DTI Study
NCT00391235
Ropinirole in the Treatment of Bipolar Depression
NCT00314821
Natural Supplements for Unipolar Depression
NCT00226356
Aripiprazole in the Treatment of Bipolar Depression
NCT00226317
A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder
NCT00195845
The Trauma Recovery and Resiliency Research Project
NCT00131534
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 4 | 5 |
Where Cambridge Health Alliance enrollment is open (later-stage tilt)
7 recruiting of 45 indexed (16% open); 30 completed (67%).
Phase mix: 5 late (III/IV) vs 3 early (I/II) (later-stage heavy).
Top condition: Pain Interference (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Cambridge Health Alliance: open-pipeline peers nationwide
Peers matched on 45 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
Cambridge Health Alliance sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 45 trials (± recruiting share)
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections · 45 trials · 4% recruiting
- AIDS Malignancy Consortium · 45 trials · 11% recruiting
- Carilion Clinic · 45 trials · 20% recruiting
- Genmab · 45 trials · 24% recruiting
Sponsors near 16% open enrollment (± trial volume)
- Louisiana State University Health Sciences Center in New Orleans · 16% recruiting · 45 trials
- Roswell Park Cancer Institute · 16% recruiting · 365 trials
- Incyte Corporation · 15% recruiting · 239 trials
- Brigham and Women's Hospital · 15% recruiting · 937 trials
Related
What to do with this Cambridge Health Alliance page
45 registered trials is a research-attention snapshot, not an endorsement of Cambridge Health Alliance or any single study.
- 7 of Cambridge Health Alliance's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Pain Interference is the condition Cambridge Health Alliance studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pain Interference trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Cambridge Health Alliance pipeline card: 45 registered trials from official public datasets.Report a data error.